Skip to content

Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases

Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06750601
Acronym
Rehablines
Enrollment
20000
Registered
2024-12-27
Start date
2023-08-01
Completion date
2044-01-31
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation

Brief summary

Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.

Interventions

None listed

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen

Exclusion criteria

* n.a.

Design outcomes

Primary

MeasureTime frameDescription
Clinical dataTimepoint 1: pre-treatment. Timepoint 2: throughout study completion (on average 12 weeks). Timepoint 3: up to 1 year follow upRehablines is a unique databank that purely re-uses clinical data for research. All data that is collected during the treatment of our patients can be re-used with patient consent.

Countries

Netherlands

Contacts

Primary ContactK van Kammen, PhD, PhD
rehablines@umcg.nl+3150 - 361 6160

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026